Darolutamide monotherapy in patients with castration-sensitive prostate cancer (CSPC) after biochemical recurrence (BCR): ARAMON lead-in phase results.
| Title: | Darolutamide monotherapy in patients with castration-sensitive prostate cancer (CSPC) after biochemical recurrence (BCR): ARAMON lead-in phase results. |
|---|---|
| Authors: | Laccetti, Andrew Leonard, Smith, Matthew R, Scher, Howard I., Nowfar, Sepehr, Einstein, David Johnson, Martin, Benjamin, Adorjan, Patrick, Dissanayake, Manjari, Verholen, Frank, Gao, Xin |
| Source: | Journal of Clinical Oncology; 2/10/2025 Supplement5, Vol. 43, p150-150, 288p |
| Database: | Supplemental Index |
| ISSN: | 0732183X |
|---|---|
| DOI: | 10.1200/JCO.2025.43.5_suppl.150 |
| Published in: | Journal of Clinical Oncology |
| Language: | English |